NCT02784210View on ClinicalTrials.gov

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 5, 2016

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Multiple Sclerosis
Interventions
DRUG

Methylprednisolone

3 days of corticosteroids (intravenous methylprednisolone at 1000 mg/day

DRUG

Prednisone

3 days of corticosteroids (oral prednisone at 1250 mg/day

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH